CAD 1.03
(1.98%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 17.11 Million USD | 1.78% |
2022 | 16.81 Million USD | -8.77% |
2021 | 18.42 Million USD | 126.28% |
2020 | 8.14 Million USD | 972.82% |
2019 | -933.01 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 2.3 Million USD | -79.22% |
2024 Q1 | 11.09 Million USD | -35.13% |
2023 Q2 | 12.36 Million USD | -8.33% |
2023 FY | 17.11 Million USD | 1.78% |
2023 Q4 | 17.11 Million USD | 94.6% |
2023 Q1 | 13.48 Million USD | -19.77% |
2023 Q3 | 8.79 Million USD | -28.89% |
2022 Q4 | 16.81 Million USD | 13.36% |
2022 FY | 16.81 Million USD | -8.77% |
2022 Q3 | 14.83 Million USD | -10.46% |
2022 Q2 | 16.56 Million USD | -0.44% |
2022 Q1 | 16.63 Million USD | -9.72% |
2021 Q4 | 18.42 Million USD | 18.68% |
2021 FY | 18.42 Million USD | 126.28% |
2021 Q2 | 14.8 Million USD | 14.12% |
2021 Q1 | 12.97 Million USD | 59.3% |
2021 Q3 | 15.52 Million USD | 4.87% |
2020 Q3 | -1.17 Million USD | 0.0% |
2020 Q4 | 8.14 Million USD | 795.63% |
2020 FY | 8.14 Million USD | 972.82% |
2019 Q4 | -933.01 Thousand USD | 0.0% |
2019 FY | -933.01 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 4.89 Million CAD | -249.65% |
CanadaBis Capital Inc. | 4.08 Million CAD | -318.95% |
Decibel Cannabis Company Inc. | 37.48 Million CAD | 54.352% |
Delivra Health Brands Inc. | -2.17 Million CAD | 887.409% |
Entourage Health Corp. | 150.32 Million CAD | 88.618% |
Lifeist Wellness Inc. | -188.12 Thousand CAD | 9195.036% |
Cannara Biotech Inc. | 41.51 Million CAD | 58.783% |
Medicure Inc. | -5.82 Million CAD | 393.741% |
PharmaCielo Ltd. | 18.24 Million CAD | 6.226% |
Rubicon Organics Inc. | 475.37 Thousand CAD | -3499.371% |
BioSyent Inc. | -3.68 Million CAD | 564.33% |
Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | -45028.313% |